InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Fust Matthew K, 董事. Insider active across 5 companies, notably Atara Biotherapeutics, Inc.. In total, 31 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €957k. Activity tracked since 8 June 2021. The latest transaction was disclosed on 1 September 2026 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Fust Matthew K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报31 总计
5,925 股@ US$85.000.0056% mcap14.2% 占其流量Common StockSEC:0001628280-26-059902:1
22,836 股@ US$85.000.022% mcap54.6% 占其流量Common StockSEC:0001628280-26-059902:0
5,925 股Common StockSEC:0001628280-26-044717:0
12,000 股Common StockSEC:0000905148-26-002920:0
10,000 股@ US$1.911.6% 占其流量Common StockSEC:0001658247-25-000010:0
16,000 股@ US$44.7561.2% 占其流量Common StockSEC:0001658247-25-000010:1
6,900 股0Common StockSEC:0000950170-25-086266:0
7,828 股0Common StockSEC:0000905148-25-002141:0
5,740 股0Common StockSEC:0000950170-25-074664:0
3,783 股@ US$8.32100.0% 占其流量Common StockSEC:0001610717-24-000511:0
5,345 股0Common StockSEC:0000950170-24-075489:0
20,100 股0Common StockSEC:0001610717-24-000335:0
3,400 股0Common StockSEC:0000950170-24-071924:0
150,000 股0Common StockSEC:0000905148-24-001060:0
12,500 股@ US$23.2426.6% 占其流量Common StockSEC:0001209191-24-005060:0
2,550 股@ US$50.8930.3% 占其流量Common StockSEC:0000950170-24-029040:0
6,000 股0Common StockSEC:0001209191-23-038819:0
3,860 股0Common StockSEC:0001209191-23-035691:0
57,000 股0Common StockSEC:0001140361-23-028152:0
5,700 股@ US$1.450.8% 占其流量Common StockSEC:0001209191-22-042245:0
3,300 股0Common StockSEC:0001209191-22-039566:0
20,500 股0Common StockSEC:0001140361-22-024164:0
7,500 股@ US$40.3769.7% 占其流量Common StockSEC:0001209191-22-016930:0
13,354 股@ US$19.50100.0% 占其流量Common StockSEC:0001567619-21-019403:0
8,954 股@ US$1.911.5% 占其流量Common StockSEC:0001209191-21-062728:0
31 条申报中的 25 条
About Fust Matthew K
Fust Matthew K is Administrateur at Crinetics Pharmaceuticals, Inc., Atara Biotherapeutics, Inc., Ultragenyx Pharmaceutical Inc. and Neumora Therapeutics, Inc. He has 29 filings in total, and across the sampled recent filings from 2021-06-09 to 2026-06-22, sales total EUR 957160 and the dominant transaction nature is Attribution.
